According to the latest research by InsightAce Analytic, the global market for phage therapy was valued at US$ 28.8 Mn and it is expected to reach US$ 116.6 million in 2027, recording a promising CAGR of 19% during the period of 2019-2027. In the current scenario, phage therapy market is not well established with no FDA approved product. Current market is driven by cPT products and natural phage platforms from local vendors such as Microgen Russia and Phage Therapy Centre, Georgia. Strong product pipeline with increasing research and development activities in phage therapy market. Approximately 76 percent of molecules are under preclinical stage and is anticipated to hit the market by late 2021. Thus, furious research and development activities in phage therapeutics has posed a key potential to meet the demand of patients and take over the side effect of resistance developed by antibiotics.
to know more